| An end to Manicheism. | |
| | |
MedLine Citation:
|
PMID: 8041879 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Although each vaccine has limitations, both OPV and E-IPV have made a considerable contribution to the effective control of polyomyelitis. In view of the complementary advantages of the two vaccines, more use of their association in a common schedule is quite justified. An association of OPV and E-IPV, in which the latter is combined with DTP, seems particularly advantageous immunologically, logistically, and economically. There are several alternative ways in which the two vaccines could be associated sequentially or simultaneously. In addition, each vaccine could be used as a booster for routine programs with the other vaccine. |
| | |
Authors:
|
S A Plotkin |
Related Documents
:
|
20148919 - A seroprevalence study of poliovirus antibody against a collection of recombinant and n... 8249429 - Serological evaluation of a simplified immunization schedule using quadruple dpt-polio ... 11228359 - Capsid and rna stabilisation of the oral polio vaccine. 7361209 - Serum antibody levels after immunization with trivalent oral poliovirus vaccine. 2169209 - Sociodemographic correlates of neutralizing poliovirus and hepatitis a virus antibodies... 7691749 - A poliovirus hybrid expressing a neutralization epitope from the major outer membrane p... 14604579 - Policymakers' views on dengue fever/dengue haemorrhagic fever and the need for dengue v... 16528969 - Vaccination with leukemia-loaded dendritic cells eradicates residual disease and preven... 18416439 - Sample size for equivalence trials: a case study from a vaccine lot consistency trial. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Public health reviews Volume: 21 ISSN: 0301-0422 ISO Abbreviation: Public Health Rev Publication Date: 1993-1994 |
Date Detail:
|
Created Date: 1994-08-22 Completed Date: 1994-08-22 Revised Date: 2006-07-19 |
Medline Journal Info:
|
Nlm Unique ID: 0370123 Medline TA: Public Health Rev Country: ISRAEL |
Other Details:
|
Languages: eng Pagination: 135-8 Citation Subset: IM |
Affiliation:
|
Pasteur Mérieux Connaught, Marnes-la-Coquette, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Diphtheria-Tetanus-Pertussis Vaccine Health Policy Humans Immunization Schedule Immunization, Secondary Poliomyelitis / prevention & control* Poliovirus Vaccine, Inactivated* / economics, immunology Poliovirus Vaccine, Oral* / economics, immunology Vaccination / economics, methods* Vaccines, Combined |
| Chemical | |
Reg. No./Substance:
|
0/Diphtheria-Tetanus-Pertussis Vaccine; 0/Poliovirus Vaccine, Inactivated; 0/Poliovirus Vaccine, Oral; 0/Vaccines, Combined |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Methods for poliomyelitis eradication: is there a consensus?
Next Document: Can we agree on a prescription? A view from the perspective of the developing countries.